0001140361-22-023329.txt : 20220616 0001140361-22-023329.hdr.sgml : 20220616 20220616205548 ACCESSION NUMBER: 0001140361-22-023329 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220614 FILED AS OF DATE: 20220616 DATE AS OF CHANGE: 20220616 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DESOUZA ERROL B CENTRAL INDEX KEY: 0001213895 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38787 FILM NUMBER: 221022206 MAIL ADDRESS: STREET 1: 215 COLLEGE ROAD CITY: PARAMUS STATE: NJ ZIP: 07652 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclerion Therapeutics, Inc. CENTRAL INDEX KEY: 0001755237 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 831895370 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-621-7722 MAIL ADDRESS: STREET 1: 301 BINNEY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 form4.xml FORM 4 X0306 4 2022-06-14 0001755237 Cyclerion Therapeutics, Inc. CYCN 0001213895 DESOUZA ERROL B C/O CYCLERION THERAPEUTICS, INC. 245 FIRST STREET, 18TH FLOOR CAMBRIDGE MA 02142 true Stock Option (Right to Buy) 0.53 2022-06-14 4 A 0 20000 0 A 2032-06-14 Common Stock 20000 20000 D The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. /s/ Gary J. Simon, Attorney-in-Fact 2022-06-16